Update of the dutch manual for costing in economic evaluations

International Journal of Technology Assessment in Health Care

Volumn 28, Issue 2, 2012, Pages 152-158

  Tan, Siok Swan ^a   Bouwmans, Clazien A M ^a   Rutten, Frans F H ^a   Hakkaart Van Roijen, Leona ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Costing manual; Costing methodology; Data sources; Reference prices; Standardization

Indexed keywords

ACTION PLAN; ALTERNATIVE METHODS; COSTING MANUAL; COSTING METHODOLOGY; DATA SOURCE; DIAGNOSIS TREATMENT COMBINATIONS; ECONOMIC EVALUATIONS; HEALTH ECONOMICS; HEALTHCARE SECTORS; REFERENCE PRICES;

ECONOMIC ANALYSIS; HEALTH CARE; STANDARDIZATION;

COSTS;

ARTICLE; CAREGIVER; HEALTH CARE COST; HEALTH ECONOMICS; MENTAL HEALTH CARE; NETHERLANDS; PRACTICE GUIDELINE;

COST-BENEFIT ANALYSIS; DECISION MAKING; DIAGNOSIS-RELATED GROUPS; EVALUATION STUDIES AS TOPIC; HEALTH CARE COSTS; HUMANS; NETHERLANDS; STATISTICS AS TOPIC;

EID: 84860744110     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462312000062     Document Type: Article

References (28)

1. Barbieri M, Drummond M, Willke R, et al. Variability of costeffectiveness estimates for pharmaceuticals in Western Europe: Lessons for inferring generalizability. Value Health. 2005;8:10-23. (Pubitemid 40293637)
2. Brouwer WB, Niessen LW, Postma MJ, Rutten FF. Need for differential discounting of costs and health effects in cost effectiveness analyses. BMJ. 2005;331:446-448. (Pubitemid 41176388)
3. Centraal Administratie Kantoor. Jaarverslag 2008. CAK: Den Haag; Juni 2009.
4. Claxton K, Paulden M, Gravelle H, Brouwer W, Culyer AJ. Discounting and decision making in the economic evaluation of health-care technologies. Health Econ. 2011;20:2-15.
5. Commonwealth of Australia. Manual of recourse items and their associated costs 2009. 4th ed. Canberra: Commonwealth of Australia; 2009.
6. Curtis L. Unit costs of health and social care 2010. 18th ed. Canterbury: University of Kent; 2010.
7. Ferguson B. NHS database of reference costs is severely flawed. BMJ. 2001;323:106. (Pubitemid 32681980)
8. Goldstein H. Multilevel statistical models. 3rd ed. New York: Oxford University Press; 2003.
9. Hakkaart-van Roijen L, Tan SS, Bouwmans-Frijters CAM. Handleiding voor kostenonderzoek: Methoden en referentieprijzen voor economische evaluaties in de gezondheidszorg, geactualiseerde versie 2010. www.cvz.nl/.
10. Hjelmgren J, Berggren F, Andersson F. Health economic guidelines- similarities, differences and some implications.Value Health. 2001;4:225-250. (Pubitemid 32661267)
11. Hoffmann C, Graf von der Schulenburg JM. The influence of economic evaluation studies on decision making. A European survey. The EUROMET group. Health Policy. 2000;52:179-192. (Pubitemid 30336269)
12. Johnston K, Buxton MJ, Jones DR, Fitzpatrick R. Assessing the costs of healthcare technologies in clinical trials. Health Technol Assess. 1999;3:1-76.
13. Koopmanschap MA, Rutten FF. A practical guide for calculating indirect costs of disease. Pharmacoeconomics. 1996;10:460-466. (Pubitemid 26359874)
14. Krauth C, Hessel F, Hansmeier T, et al. [Empirical standard costs for health economic evaluation in Germany - a proposal by the working group methods in health economic evaluation]. Gesundheitswesen. 2005;67:736-746. (Pubitemid 41604934)
15. Oostenbrink JB,Koopmanschap MA, Rutten FF. Standardisation of costs: The Dutch Manual for Costing in economic evaluations. Pharmacoeconomics. 2002;20:443-454. (Pubitemid 34804173)
16. Raftery J, Roderick P, Stevens A. Potential use of routine databases in health technology assessment. Health Technol Assess. 2005;9:1-92, iii-iv.
17. Raikou M, Briggs A, Gray A, McGuire A. Centre-specific or average unit costs in multi-centre studies? Some theory and simulation. Health Econ. 2000;9:191-198. (Pubitemid 30248636)
18. Rappange DR, van Baal PH, van Exel NJ, et al. Unrelated medical costs in life-years gained: Should they be included in economic evaluations of healthcare interventions? Pharmacoeconomics. 2008;26:815-830.
19. Rodenburg-van Dieten HEM. Richtlijnen voor Farmaco-Economisch Onderzoek; Evaluatie en Actualisatie.Diemen: College voor zorgverzekeringen; 2005.
20. Rutten-vanMolkenM. Van kosten tot effecten: Een handleiding voor evaluatiestudies in de gezondheidszorg. 2nd ed. Maarssen: Elsevier gezondheidszorg; 2010.
21. Swindle R, Lukas CV, Meyer DA, Barnett PG, Hendricks AM. Cost analysis in the Department of Veterans Affairs: Consensus and future directions. Med Care. 1999;37:AS3-AS8.
22. Tan SS. Microcosting in economic evaluations: Issues of accuracy, feasibility, consistency and generalisability. http://publishing.eur.nl/ir/ repub/ asset/17354/091127-Tan,%20Siok%20Swan.pdf. 1st ed. Rotterdam: Erasmus Universiteit Rotterdam; 2009.
23. Tan SS, van Ineveld BM, Redekop WK, Hakkaart-van Roijen L. The Netherlands: The diagnose behandeling combinaties (DBCs). In: Busse R, Geissler A, Quentin W, Wiley MM, eds. Diagnosis-related groups in Europe:Moving towards transparency, efficiency and quality in hospitals, 1st ed. Buckingham: Open University Press and WHO Regional Office for Europe; 2011.
24. Tan SS, Rutten FF, van Ineveld BM, Redekop WK, Hakkaart-van Roijen L. Comparing methodologies for the cost estimation of hospital services. Eur J Health Econ. 2009;10:39-45.
25. van Baal P, Brouwer W. PAID 1.0 in practice: A brief clarification regarding its possibilities and limitations. Pharmacoeconomics. 2011;29:545-547.
26. van den Hout WB. The value of productivity: Human-capital versus friction-cost method. Ann Rheum Dis. 2010;69(Suppl 1):i89-i91.
27. Weinstein MC, O'Brien B, Hornberger J, et al. Principles of good practice for decision analytic modeling in health-care evaluation: Report of the ISPOR Task Force on Good Research Practices-Modeling Studies. Value Health. 2003;6:9-17. (Pubitemid 36228345)
28. Wordsworth S, Ludbrook A, Caskey F, Macleod A. Collecting unit cost data in multicentre studies. Creating comparable methods. Eur J Health Econ. 2005;6:38-44. (Pubitemid 40543269)